San Mateo Press

BeiGene's BGB-16673 Receives U.S. FDA Fast Track Designation for CLL/SLL | Nasdaq

SAN MATEO, Calif.–(BUSINESS WIRE)– BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the …

Continue

Do you trust this headline?

Based on recent headline ratings, 88% of this readership currently trusts the local media, which has an average score of 82% regionally and is currently trending positivepositive.

88%

Media Trust Score88%

Read All

In